IRBs and Pharmaceutical Company Funding of Research

IRB: Ethics & Human Research 4 (8):9 (1982)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.2307/3564273

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,197

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Pharmaceutical company funding and its consequences: A qualitative systematic review.Sergio Sismondo - manuscript
Funding, objectivity and the socialization of medical research.James Robert Brown - 2002 - Science and Engineering Ethics 8 (3):295--308.
Views and Experiences of IRBs Concerning Research Integrity.Robert Klitzman - 2011 - Journal of Law, Medicine and Ethics 39 (3):513-528.
The Ethics of Pharmaceutical Research Funding: A Social Organization Approach.Garry C. Gray - 2013 - Journal of Law, Medicine and Ethics 41 (3):629-634.
Commentary: The Voice of the People, Funded Now by Your Friendly Pharmaceutical Company.Ray Moynihan - 2020 - Journal of Bioethical Inquiry 17 (1):61-63.
Us irbs confronting research in the developing world.Robert L. Klitzman - 2012 - Developing World Bioethics 12 (2):63-73.
Institutional Corruption and the Pharmaceutical Policy.Marc A. Rodwin - 2013 - Journal of Law, Medicine and Ethics 41 (3):544-552.
Third-Party Risks in Research: Should IRBs Address Them?Daniel Hausman - 2007 - IRB: Ethics & Human Research 29 (3).
Data-Sharing Dilemmas: Allowing Pharmaceutical Company Access to Research Data.James Anderson & Toby Schonfeld - 2009 - IRB: Ethics & Human Research 31 (3):17-19.
The Nuts and Bolts of IRBs.Don Workman - 2007 - IRB: Ethics & Human Research 29 (2).
How Independent Are IRBs?Ruth Macklin - 2008 - IRB: Ethics & Human Research 30 (3).
Protecting Research Subjects: IRBs in a Changing Research Landscape.Ann Cook & Helena Hoas - 2011 - IRB: Ethics & Human Research 33 (2):14-19.
Private-sector research ethics: Marketing or good conflicts management? The 2005 John J. Conley lecture on medical ethics. [REVIEW]Rebecca Dresser - 2006 - Theoretical Medicine and Bioethics 27 (2):115-139.
Institutional Barriers to Research on Sensitive Topics: Case of Sex Communication Research Among University Students.Carey M. Noland - 2012 - Journal of Research Practice 8 (1):Article - M2.
The pharmaceutical physician and the company medical department.D. M. Burley - 1985 - In D. M. Burley & T. B. Binns (eds.), Pharmaceutical Medicine. E. Arnold. pp. 260--282.

Analytics

Added to PP
2021-04-28

Downloads
7 (#1,391,414)

6 months
6 (#529,161)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references